Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Dr. James A. HelliwellCEO & Director | 150,00k | 83,43k | Derivative Exercise and Retained Stock | 0,56 | 1,06M | 16,57% |
| 2026-03-09 | Dr. Richard M. GlickmanIndependent Director | -3,13k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-27 | Dr. Simon N. PimstoneIndependent Chairman | 12,00k | 81,82k | Kauf | 6,77 - 6,88 | 48,68k | 32,72% |
| 2026-03-27 | Dr. James A. HelliwellCEO & Director | 30,00k | 64,88k | Derivative Exercise and Retained Stock | 2,16 | 905,01k | 3,43% |
| 2026-03-18 | Mr. Joseph S. FreedmanIndependent Director | 18,70k | 145,85k | Kauf | 7,42 - 7,97 | 2,54M | 0,74% |
| 2026-03-18 | PNG Enterprise FoundationUnternehmen | -15,00k | 85,45k | Derivative Exercise and Sale | 2,19 - 7,89 | 33,73k | - |
| 2026-03-18 | PNG Enterprise FoundationUnternehmen | 33,73k | 73,89k | Derivative Exercise and Retained Stock | 2,19 | 33,73k | - |
| 2026-03-16 | Mr. Paul L. GeyerIndependent Director | -48,73k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-08 | Dr. Richard M. GlickmanIndependent Director | -3,13k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Mr. Paul L. GeyerIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Mr. John Salvatore MontalbanoIndependent Director | -21,88k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-09 | Dr. Michael WilminkIndependent Director | -1,53k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2026-03-02 | Mr. Joseph S. FreedmanIndependent Director | 170,00k | 371,93k | Derivative Exercise and Retained Stock | 2,19 | 2,52M | 7,22% |
| 2026-02-20 | Mr. Joseph S. FreedmanIndependent Director | 280,00k | 1,96M | Kauf | 7,00 | 2,35M | 13,50% |
| 2026-02-02 | Mr. John Salvatore MontalbanoIndependent Director | 243,90k | 534,87k | Derivative Exercise and Retained Stock | 2,19 | 1,54M | 18,87% |
| 2026-01-23 | Mr. Alexander John RothwellCFO | 104,00k | 227,19k | Derivative Exercise and Retained Stock | 2,18 | 1,10M | 10,40% |
| 2026-01-23 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 5,00k | 40,78k | Derivative Exercise and Retained Stock | 8,16 | 48,50k | 11,49% |
| 2025-12-15 | Dr. Richard M. GlickmanIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 6,27 | 260,00k | 8,33% |
| 2025-12-15 | Mr. Alexander John RothwellCFO | 231,25k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 446,25k | 107,56% |
| 2025-12-15 | Dr. Amanda MaloneChief Scientific Officer & COO | 285,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 861,00k | 49,61% |
| 2025-12-15 | Dr. Simon N. PimstoneIndependent Chairman | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 302,50k | 7,08% |
| 2025-12-15 | Mr. Paul L. GeyerIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 238,75k | 9,14% |
| 2025-12-15 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 80,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 340,00k | 30,77% |
| 2025-12-15 | Mr. John Salvatore MontalbanoIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 246,25k | 8,84% |
| 2025-12-15 | Dr. Mark M. KowalskiInsider | 85,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 395,00k | 27,42% |
| 2025-12-15 | Dr. Michael WilminkIndependent Director | 20,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 222,50k | 9,88% |
| 2025-11-24 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 16,30k | 101,92k | Kauf | 6,23 - 6,30 | 43,50k | 59,93% |
| 2025-11-15 | Dr. Simon N. PimstoneIndependent Chairman | 25,00k | 142,65k | Derivative Exercise and Retained Stock | 5,71 | 36,68k | 214,08% |
| 2025-11-14 | Mr. John Salvatore MontalbanoIndependent Director | 12,50k | 71,32k | Derivative Exercise and Retained Stock | 5,71 | 1,29M | 0,98% |
| 2025-11-02 | Dr. Simon N. PimstoneIndependent Chairman | -25,00k | 0,00 | Other Derivative Disposition | - | 282,50k | -8,13% |
| 2025-11-02 | Mr. Paul L. GeyerIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 218,75k | -5,41% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100,50k | 53,32k | Derivative Exercise and Retained Stock | 0,53 | 875,01k | 12,98% |
| 2025-11-02 | Mr. John Salvatore MontalbanoIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 226,25k | -5,24% |
| 2025-11-02 | Dr. Amanda MaloneChief Scientific Officer & COO | -3,75k | 0,00 | Other Derivative Disposition | - | 575,50k | -0,65% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100,50k | 35,43k | Derivative Exercise and Retained Stock | 0,35 | 875,01k | 12,98% |
| 2025-11-02 | Dr. James A. HelliwellCEO & Director | -18,75k | 0,00 | Other Derivative Disposition | - | 1,28M | -1,45% |
| 2025-11-02 | Dr. Michael WilminkIndependent Director | -12,50k | 0,00 | Other Derivative Disposition | - | 202,50k | -5,81% |
| 2025-09-23 | Dr. Richard M. GlickmanIndependent Director | 4,93k | 27,12k | Kauf | 5,50 | 18,86k | 35,39% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -1,50k | 0,00 | Other Disposition | - | 2,07M | -0,07% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -3,50k | 0,00 | Other Disposition | - | 2,07M | -0,17% |
| 2025-09-24 | Dr. Simon N. PimstoneIndependent Chairman | 3,05k | 16,79k | Kauf | 5,50 | 11,68k | 35,38% |
| 2025-09-24 | Mr. Joseph S. FreedmanIndependent Director | 240,79k | 1,32M | Kauf | 5,50 | 2,08M | 13,11% |
| 2025-09-24 | Mr. John Salvatore MontalbanoIndependent Director | 67,27k | 370,00k | Kauf | 5,50 | 1,28M | 5,55% |
| 2025-09-24 | Dr. Michael WilminkIndependent Director | 3,36k | 18,50k | Kauf | 5,50 | 228,23k | 1,50% |
| 2025-05-13 | Dr. Simon N. PimstoneIndependent Chairman | 43,75k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 307,50k | 16,59% |
| 2025-05-13 | Mr. Paul L. GeyerIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 231,25k | 12,12% |
| 2025-05-13 | Mr. John Salvatore MontalbanoIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 238,75k | 11,70% |
| 2025-05-13 | Dr. Amanda MaloneChief Scientific Officer & COO | 12,50k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 579,25k | 2,21% |
| 2025-05-13 | Dr. James A. HelliwellCEO & Director | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,29M | 4,02% |
| 2025-05-13 | Dr. Michael WilminkIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 215,00k | 13,16% |
| 2025-06-16 | Mr. Joseph S. FreedmanIndependent Director | 33,40k | 134,95k | Kauf | 3,89 - 4,34 | 1,53M | 2,22% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
